ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01042769
Recruitment Status : Completed
First Posted : January 6, 2010
Last Update Posted : November 2, 2016
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2013
  Actual Study Completion Date : November 2013
  Certification/Extension First Submitted : July 20, 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):